Alam Kamran

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Alam Kamran's trades of Taysha Gene Therapies Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
2.62
Quantity 33,000
Value US$86,460
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-06 2026-02-04
S Sale
36,978 +42.4%
73.12
US$1,087,384 		36,978 +42.4% 73.12 US$1,087,384
2026-02-04 2026-02-04
PrS Proposed sale
21,563
368.79
US$1,921,372 		21,563 368.79 US$1,921,372
2026-01-27 2026-01-26
S Sale
10,048 +14.9%
121.37
US$3,657,280 		10,048 +14.9% 121.37 US$3,657,280
2026-01-27 2026-01-23
S Sale
78,968 -5.1%
4.75
US$375,098 		78,968 -5.1% 4.75 US$375,098
2026-01-23 2026-01-23
PrS Proposed sale
100,846
5.09
US$513,306 		100,846 5.09 US$513,306
2025-08-22 2025-08-21
S Sale
54,491 -4.4%
2.85
US$155,299 		54,491 -4.4% 2.85 US$155,299
2025-08-21 2025-08-21
PrS Proposed sale
54,491
2.87
US$156,389 		54,491 2.87 US$156,389
2023-08-25 2023-08-24
PlS Planned sale
33,000 -11.3%
2.33
US$76,890 		33,000 -11.3% 2.33 US$76,890
2023-08-24 2023-08-24
PrS Proposed sale
33,000
2.62
US$86,460 		33,000 2.62 US$86,460
2022-08-24 2022-08-23
PlS Planned sale
3,325 -1.2%
3.47
US$11,538 		3,325 -1.2% 3.47 US$11,538
2022-08-22 2022-08-22
PlS Planned sale
9,717 -3.5%
3.50
US$34,010 		9,717 -3.5% 3.50 US$34,010
2022-08-22 2022-08-19
PlS Planned sale
11,482 -4.0%
3.75
US$43,058 		11,482 -4.0% 3.75 US$43,058
2022-08-22 2022-08-18
PlS Planned sale
7,476 -2.5%
3.87
US$28,932 		7,476 -2.5% 3.87 US$28,932